A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Application of molecular targeted therapy for refractory metastatic thyroid cancers
2016
Integrative Cancer Science and Therapeutics
Thyroid cancer is one of the leading causes of death worldwide. There have been several risks factors linked with thyroid cancer such as genetics, exposure to radiation, body weight and insulin resistance. Poorly differentiated and recurrent metastatic thyroid cancer cell carcinoma remains a therapeutic challenge because of its strong resistance to both chemotherapy and radiation therapy. Immunotherapy might play a role in the treatment of patients with metastatic thyroid cancer. In this paper,
doi:10.15761/icst.1000195
fatcat:ya4fzxdu4jb4rcg4ovufzxmmni